/PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the following distinguished Key Opinion Leaders will be.
Telix Briefing: Innovation in Urology to Feature Key Opinion Leaders in Prostate and Kidney Cancer fnarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fnarena.com Daily Mail and Mail on Sunday newspapers.
Sia Daneshmand, MD, discusses the rationale for investigating TAR-200 for the treatment of patients with Bacillus Calmette-Guérin-unresponsive, high-risk non–muscle-invasive bladder cancer, expands on the preliminary efficacy and safety data from the SunRISe-1 trial, and more.
SACRAMENTO — Governor Gavin Newsom today announced the following appointments: Susan Masten, 70, of Klamath, has been appointed Supervisor for the 5th District…
AUA 2021 Bone Health and Radionuclide Therapy, bone health in CRPC, Advanced prostate cancer AUA/ASTRO/SUO 2020 guideline, phase III ALSYMPCA trial of radium-223, symptomatic skeletal-related event, benefit of radium-223.